Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,613 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
External beam radiotherapy for clinically localized hormone-refractory prostate cancer: clinical significance of Nadir prostate-specific antigen value within 12 months.
Ogawa K, Nakamura K, Sasaki T, Onishi H, Koizumi M, Shioyama Y, Araya M, Mukumoto N, Mitsumori M, Teshima T; Japanese Patterns of Care Study Working Subgroup of Prostate Cancer. Ogawa K, et al. Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):759-65. doi: 10.1016/j.ijrobp.2008.08.067. Epub 2009 Mar 26. Int J Radiat Oncol Biol Phys. 2009. PMID: 19327908
Dose-volume histogram predictors of chronic gastrointestinal complications after radical hysterectomy and postoperative concurrent nedaplatin-based chemoradiation therapy for early-stage cervical cancer.
Isohashi F, Yoshioka Y, Mabuchi S, Konishi K, Koizumi M, Takahashi Y, Ogata T, Maruoka S, Kimura T, Ogawa K. Isohashi F, et al. Among authors: ogawa k. Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):728-34. doi: 10.1016/j.ijrobp.2012.05.021. Epub 2012 Jun 23. Int J Radiat Oncol Biol Phys. 2013. PMID: 22727885
Dose reduction trial from 60 Gy in 10 fractions to 54 Gy in 9 fractions schedule in high-dose-rate interstitial brachytherapy for early oral tongue cancer.
Akiyama H, Yoshida K, Shimizutani K, Yamazaki H, Koizumi M, Yoshioka Y, Kakimoto N, Murakami S, Furukawa S, Ogawa K. Akiyama H, et al. Among authors: ogawa k. J Radiat Res. 2012 Sep;53(5):722-6. doi: 10.1093/jrr/rrs027. Epub 2012 Jun 28. J Radiat Res. 2012. PMID: 22843365 Free PMC article. Clinical Trial.
The usefulness of an independent patient-specific treatment planning verification method using a benchmark plan in high-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix.
Takahashi Y, Koizumi M, Sumida I, Isohashi F, Ogata T, Akino Y, Yoshioka Y, Maruoka S, Inoue S, Konishi K, Ogawa K. Takahashi Y, et al. Among authors: ogawa k. J Radiat Res. 2012 Nov 1;53(6):936-44. doi: 10.1093/jrr/rrs035. Epub 2012 Jul 17. J Radiat Res. 2012. PMID: 22843371 Free PMC article.
Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M, Mabuchi S, Isohashi F, Suzuki O, Yoshioka Y, Sasano T, Ohta Y, Kamiura S, Ogawa K, Kimura T. Okazawa M, et al. Among authors: ogawa k. Int J Gynecol Cancer. 2013 Mar;23(3):567-75. doi: 10.1097/IGC.0b013e31828703fd. Int J Gynecol Cancer. 2013. PMID: 23385284
5,613 results